COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE SECONDARY PREVENTION OF RECURRENT DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN THE UNITED KINGDOM

被引：1
|
作者：
Wolowacz, S. [1 ]
Brockbank, J. [2 ]
Sunderland, T. J. [3 ]
Gonschior, A. K. [4 ]
机构：
[1] RTI Hlth Solut, Manchester, Lancs, England
[2] RTI Hlth Solut, Didsbury, England
[3] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England
[4] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1280
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A526 / A526
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS OF BEMIPARIN USED AS ACUTE TREATMENT FOR DEEP VENOUS THROMBOSIS WITHOUT PULMONARY EMBOLISM
    Aguirre, A.
    Carlos, F.
    Naranjo, M.
    Fernandez, C.
    VALUE IN HEALTH, 2015, 18 (07) : A392 - A392
  • [42] Recurrent pulmonary embolism - Is filarial lymphedema a risk factor for deep vein thrombosis?
    Boo, Yang Liang
    Lim, Hong Tak
    Chin, Pek Woon
    Lim, Suat Yee
    Hoo, Fan Kee
    RAWAL MEDICAL JOURNAL, 2016, 41 (02): : 259 - 261
  • [43] Rivaroxaban: A Review of Its Use in the Treatment of Deep Vein Thrombosis or Pulmonary Embolism and the Prevention of Recurrent Venous Thromboembolism
    Burness, Celeste B.
    Perry, Caroline M.
    DRUGS, 2014, 74 (02) : 243 - 262
  • [44] Rivaroxaban: A Review of Its Use in the Treatment of Deep Vein Thrombosis or Pulmonary Embolism and the Prevention of Recurrent Venous Thromboembolism
    Celeste B. Burness
    Caroline M. Perry
    Drugs, 2014, 74 : 243 - 262
  • [45] COST-EFFECTIVENESS OF DIAGNOSIS OF DEEP-VEIN THROMBOSIS IN SYMPTOMATIC PATIENTS
    HULL, RD
    FELDSTEIN, W
    PINEO, GF
    RASKOB, GE
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (01) : 189 - 196
  • [46] Cost-effectiveness of the deep vein thrombosis diagnosis process in primary care
    Fuentes Camps, Eva
    del Val Garcia, Jose Luis
    Bellmunt Montoya, Sergi
    Hmimina Hmimina, Sara
    Gomez Jabalera, Efren
    Munoz Perez, Miguel Angel
    ATENCION PRIMARIA, 2016, 48 (04): : 251 - 257
  • [47] THE COST-EFFECTIVENESS ANALYSIS IN SCREENING OF DEEP VEIN THROMBOSIS IN A CLINICAL LABORATORY
    Bogavac-Stanojevic, N.
    Dopsaj, V
    Vasic, D.
    Jelic-Ivanovic, Z.
    VALUE IN HEALTH, 2009, 12 (07) : A332 - A332
  • [48] Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis
    de Jong, Cindy M. M.
    van den Hout, Wilbert B.
    van Dijk, Christel E.
    Heim, Noor
    van Dam, Lisette F.
    Dronkers, Charlotte E. A.
    Gautam, Gargi
    Ghanima, Waleed
    Gleditsch, Jostein
    von Heijne, Anders
    Hofstee, Herman M. A.
    Hovens, Marcel M. C.
    Huisman, Menno V.
    Kolman, Stan
    Mairuhu, Albert T. A.
    van Mens, Thijs E.
    Nijkeuter, Mathilde
    van de Ree, Marcel A.
    van Rooden, Cornelis J.
    Westerbeek, Robin E.
    Westerink, Jan
    Westerlund, Eli
    Kroft, Lucia J. M.
    Klok, Frederikus A.
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (06) : 557 - 567
  • [49] Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention
    Yip, James
    Bruno, David A.
    Burmeister, Charlotte
    Kazimi, Marwan
    Yoshida, Atsushi
    Abouljoud, Marwan S.
    Schnickel, Gabriel T.
    TRANSPLANTATION DIRECT, 2016, 2 (04):
  • [50] Prevention and Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Critically Ill Patients
    Yang, Jack C.
    CRITICAL CARE NURSING QUARTERLY, 2005, 28 (01) : 72 - 79
12345